These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Autologous stem cell transplantation for patients with active Hodgkin's lymphoma: long-term outcome of 61 patients from a single institution. Martínez C; Salamero O; Arenillas L; Duque J; López-Guillermo A; Rovira M; Urbano-Ispízua A; Fernández-Avilés F; Carreras E; Montserrat E Leuk Lymphoma; 2007 Oct; 48(10):1968-75. PubMed ID: 17917965 [TBL] [Abstract][Full Text] [Related]
8. High-dose chemo/radiotherapy and autologous bone marrow or stem cell transplantation for poor-risk advanced-stage Hodgkin's disease during first partial or complete remission. Nademanee A; Molina A; Fung H; Stein A; Parker P; Planas I; O'Donnell MR; Snyder DS; Kashyap A; Spielberger R; Bhatia R; Krishnan A; Sniecinski I; Vora N; Slovak M; Dagis A; Niland JC; Forman SJ Biol Blood Marrow Transplant; 1999; 5(5):292-8. PubMed ID: 10534059 [TBL] [Abstract][Full Text] [Related]
9. The timing of autologous stem cell transplantation and the prognostic factors affecting the prognosis in children with relapsed Hodgkin lymphoma. Ataş E; Kesik V; Babacan O; Korkmazer N; Akyüz C Pediatr Transplant; 2015 Jun; 19(4):380-4. PubMed ID: 25752654 [TBL] [Abstract][Full Text] [Related]
11. New prognostic score based on treatment outcome of patients with relapsed Hodgkin's lymphoma registered in the database of the German Hodgkin's lymphoma study group. Josting A; Franklin J; May M; Koch P; Beykirch MK; Heinz J; Rudolph C; Diehl V; Engert A J Clin Oncol; 2002 Jan; 20(1):221-30. PubMed ID: 11773173 [TBL] [Abstract][Full Text] [Related]
12. Autotransplants for Hodgkin's disease in first relapse or second remission: a report from the autologous blood and marrow transplant registry (ABMTR). Lazarus HM; Loberiza FR; Zhang MJ; Armitage JO; Ballen KK; Bashey A; Bolwell BJ; Burns LJ; Freytes CO; Gale RP; Gibson J; Herzig RH; LeMaistre CF; Marks D; Mason J; Miller AM; Milone GA; Pavlovsky S; Reece DE; Rizzo JD; van Besien K; Vose JM; Horowitz MM Bone Marrow Transplant; 2001 Feb; 27(4):387-96. PubMed ID: 11313668 [TBL] [Abstract][Full Text] [Related]
13. Risk-adapted salvage treatment with single or tandem autologous stem-cell transplantation for first relapse/refractory Hodgkin's lymphoma: results of the prospective multicenter H96 trial by the GELA/SFGM study group. Morschhauser F; Brice P; Fermé C; Diviné M; Salles G; Bouabdallah R; Sebban C; Voillat L; Casasnovas O; Stamatoullas A; Bouabdallah K; André M; Jais JP; Cazals-Hatem D; Gisselbrecht C; J Clin Oncol; 2008 Dec; 26(36):5980-7. PubMed ID: 19018090 [TBL] [Abstract][Full Text] [Related]
14. [Autologous stem cell transplantation in the treatment of Hodgkin's disease]. Tarabar O; Tukić L; Stamatović D; Balint B; Elez M; Ostojić G; Tatomirović Z; Marjanović S Vojnosanit Pregl; 2009 Jul; 66(7):571-6. PubMed ID: 19678583 [TBL] [Abstract][Full Text] [Related]
15. BEAM chemotherapy followed by autologous stem cell support in lymphoma patients: analysis of efficacy, toxicity and prognostic factors. Caballero MD; Rubio V; Rifon J; Heras I; García-Sanz R; Vázquez L; Vidriales B; del Cañizo MC; Corral M; Gonzalez M; León A; Jean-Paul E; Rocha E; Moraleda JM; San Miguel JF Bone Marrow Transplant; 1997 Sep; 20(6):451-8. PubMed ID: 9313877 [TBL] [Abstract][Full Text] [Related]
16. Autologous stem cell transplantation for poor prognosis Hodgkin's disease in first complete remission: a retrospective study from the Spanish GEL-TAMO cooperative group. Sureda A; Mataix R; Hernández-Navarro F; Jarque I; Lahuerta JJ; Tomás JF; Brunet S; Caballero D; Conde E; León A; Fernández MN; López A; Maldonado J; Bengoechea E; Callís M; Carrera D; García-Conde J; García-Laraña J; Moraleda JM; Morey M; Rifón J; Sierra J; Torres A; Domingo-Albós A Bone Marrow Transplant; 1997 Aug; 20(4):283-8. PubMed ID: 9285542 [TBL] [Abstract][Full Text] [Related]
17. High-dose therapy in diffuse large cell lymphoma: results and prognostic factors in 452 patients from the GEL-TAMO Spanish Cooperative Group. Caballero MD; Pérez-Simón JA; Iriondo A; Lahuerta JJ; Sierra J; Marín J; Gandarillas M; Arranz R; Zuazu J; Rubio V; Fernández de Sevilla A; Carreras E; García-Conde J; García-Laraña J; Grande C; Sureda A; Vidal MJ; Rifón J; Pérez-Equiza C; Varela R; Moraleda JM; García Ruíz JC; Albó C; Cabrera R; San Miguel JF; Conde E Ann Oncol; 2003 Jan; 14(1):140-51. PubMed ID: 12488306 [TBL] [Abstract][Full Text] [Related]
18. Autologous stem cell transplantation (ASCT) for poor prognostic Hodgkin's disease (HD): comparative results with two CBV regimens and importance of disease status at transplant. Arranz R; Tomás JF; Gil-Fernández JJ; Martínez-Chamorro C; Granados E; Alegre A; Figuera A; Vázquez L; Cámara R; Fernández-Rañada JM Bone Marrow Transplant; 1998 Apr; 21(8):779-86. PubMed ID: 9603401 [TBL] [Abstract][Full Text] [Related]
19. Prognostic factors for survival after high-dose therapy and autologous stem cell transplantation for patients with relapsing Hodgkin's disease: analysis of 280 patients from the French registry. Société Française de Greffe de Moëlle. Brice P; Bouabdallah R; Moreau P; Divine M; André M; Aoudjane M; Fleury J; Anglaret B; Baruchel A; Sensebe L; Colombat P Bone Marrow Transplant; 1997 Jul; 20(1):21-6. PubMed ID: 9232251 [TBL] [Abstract][Full Text] [Related]
20. High-dose therapy and autologous stem-cell transplantation for adult patients with Hodgkin's disease who do not enter remission after induction chemotherapy: results in 175 patients reported to the European Group for Blood and Marrow Transplantation. Lymphoma Working Party. Sweetenham JW; Carella AM; Taghipour G; Cunningham D; Marcus R; Della Volpe A; Linch DC; Schmitz N; Goldstone AH J Clin Oncol; 1999 Oct; 17(10):3101-9. PubMed ID: 10506605 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]